Literature DB >> 3722412

Lymphocytic infiltration and survival in rectal cancer.

J R Jass.   

Abstract

Lymphocytic infiltration was assessed semiquantitatively in 447 specimens of rectal cancer. Corrected five year survivals for pronounced, moderate, and little lymphocytic infiltration were 92%, 65% and 36%, respectively. Grading was shown to be reproducible in an intraobserver study (observed agreement 81%, expected agreement 34%, kappa coefficient 0.72). In the multivariate survival analysis of grade and stage related variables lymphocytic infiltration was the only grade related variable to be accepted within the prognostic model. This model also included the number of lymph node metastases and the extent of tumour spread. It is suggested that the conservation of the normal interactive traffic between epithelium and mucosa associated lymphoid tissue (MALT) signals a low grade growth. This is supported by the association between lymphocytic infiltration and the expression of secretory component by malignant epithelium.

Entities:  

Mesh:

Year:  1986        PMID: 3722412      PMCID: PMC499954          DOI: 10.1136/jcp.39.6.585

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  25 in total

1.  HLA-DR expression in a human colonic carcinoma cell line.

Authors:  I A Lampert; S Kirkland; S Farrell; L K Borysiewicz
Journal:  J Pathol       Date:  1985-08       Impact factor: 7.996

2.  Prognostic correlations of operable carcinoma of the rectum.

Authors:  C A Carlon; G Fabris; C Arslan-Pagnini; A M Pluchinotta; E Chinelli; S Carniato
Journal:  Dis Colon Rectum       Date:  1985-01       Impact factor: 4.585

3.  Prognostic factors in colon carcinoma: correlation of serum carcinoembryonic antigen level and tumor histopathology.

Authors:  N Zamcheck; W G Doos; R Prudente; B B Lurie; L S Gottlieb
Journal:  Hum Pathol       Date:  1975-01       Impact factor: 3.466

4.  The value of secretory component (SC) immunoreactivity in diagnosis and prognosis of colorectal carcinomas.

Authors:  J W Arends; T Wiggers; C T Thijs; C Verstijnen; G J Swaen; F T Bosman
Journal:  Am J Clin Pathol       Date:  1984-09       Impact factor: 2.493

5.  Multivariate analysis of prognostic factors for operable rectal cancer.

Authors:  L S Freedman; P Macaskill; A N Smith
Journal:  Lancet       Date:  1984-09-29       Impact factor: 79.321

6.  The analysis of mononuclear cell infiltrations in colorectal adenocarcinoma.

Authors:  B Koch; J Giedl; P Hermanek; J R Kalden
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

7.  Surgical treatment and late results in 1226 cases of colorectal cancer.

Authors:  X G Zhou; B M Yu; Y X Shen
Journal:  Dis Colon Rectum       Date:  1983-04       Impact factor: 4.585

8.  Induction of HLA class-II antigen expression on human carcinoma cell lines by IFN-Gamma.

Authors:  R Schwartz; F Momburg; G Moldenhauer; B Dörken; V Schirrmacher
Journal:  Int J Cancer       Date:  1985-02-15       Impact factor: 7.396

9.  Isolation and initial characterization of tumoricidal monokine(s) from the human monocytic leukemia cell line THP-1.

Authors:  C A Armstrong; J Klostergaard; G A Granger
Journal:  J Natl Cancer Inst       Date:  1985-01       Impact factor: 13.506

10.  Distribution of histocompatibility and leucocyte differentiation antigens in normal human colon and in benign and malignant colonic neoplasms.

Authors:  A Csiba; H L Whitwell; M Moore
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640

View more
  107 in total

Review 1.  Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.

Authors:  Shona Hendry; Roberto Salgado; Thomas Gevaert; Prudence A Russell; Tom John; Bibhusal Thapa; Michael Christie; Koen van de Vijver; M V Estrada; Paula I Gonzalez-Ericsson; Melinda Sanders; Benjamin Solomon; Cinzia Solinas; Gert G G M Van den Eynden; Yves Allory; Matthias Preusser; Johannes Hainfellner; Giancarlo Pruneri; Andrea Vingiani; Sandra Demaria; Fraser Symmans; Paolo Nuciforo; Laura Comerma; E A Thompson; Sunil Lakhani; Seong-Rim Kim; Stuart Schnitt; Cecile Colpaert; Christos Sotiriou; Stefan J Scherer; Michail Ignatiadis; Sunil Badve; Robert H Pierce; Giuseppe Viale; Nicolas Sirtaine; Frederique Penault-Llorca; Tomohagu Sugie; Susan Fineberg; Soonmyung Paik; Ashok Srinivasan; Andrea Richardson; Yihong Wang; Ewa Chmielik; Jane Brock; Douglas B Johnson; Justin Balko; Stephan Wienert; Veerle Bossuyt; Stefan Michiels; Nils Ternes; Nicole Burchardi; Stephen J Luen; Peter Savas; Frederick Klauschen; Peter H Watson; Brad H Nelson; Carmen Criscitiello; Sandra O'Toole; Denis Larsimont; Roland de Wind; Giuseppe Curigliano; Fabrice André; Magali Lacroix-Triki; Mark van de Vijver; Federico Rojo; Giuseppe Floris; Shahinaz Bedri; Joseph Sparano; David Rimm; Torsten Nielsen; Zuzana Kos; Stephen Hewitt; Baljit Singh; Gelareh Farshid; Sibylle Loibl; Kimberly H Allison; Nadine Tung; Sylvia Adams; Karen Willard-Gallo; Hugo M Horlings; Leena Gandhi; Andre Moreira; Fred Hirsch; Maria V Dieci; Maria Urbanowicz; Iva Brcic; Konstanty Korski; Fabien Gaire; Hartmut Koeppen; Amy Lo; Jennifer Giltnane; Marlon C Rebelatto; Keith E Steele; Jiping Zha; Kenneth Emancipator; Jonathan W Juco; Carsten Denkert; Jorge Reis-Filho; Sherene Loi; Stephen B Fox
Journal:  Adv Anat Pathol       Date:  2017-11       Impact factor: 3.875

2.  Poorly differentiated colonic adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics.

Authors:  J Rüschoff; W Dietmaier; J Lüttges; G Seitz; T Bocker; H Zirngibl; J Schlegel; H K Schackert; K W Jauch; F Hofstaedter
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

3.  Morphological predictors of survival in early and advanced gastric carcinoma.

Authors:  P Schmitz-Moormann; P Hermanek; G W Himmelmann
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

4.  Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.

Authors:  Eiichi Sato; Sara H Olson; Jiyoung Ahn; Brian Bundy; Hiroyoshi Nishikawa; Feng Qian; Achim A Jungbluth; Denise Frosina; Sacha Gnjatic; Christine Ambrosone; James Kepner; Tosin Odunsi; Gerd Ritter; Shashikant Lele; Yao-Tseng Chen; Haruo Ohtani; Lloyd J Old; Kunle Odunsi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

5.  Reporting colorectal cancer.

Authors:  H G Penman
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

6.  Tumor lymphocyte immune response to preoperative radiotherapy in locally advanced rectal cancer: The LYMPHOREC study.

Authors:  C Mirjolet; C Charon-Barra; S Ladoire; F Arbez-Gindre; A Bertaut; F Ghiringhelli; A Leroux; D Peiffert; C Borg; J F Bosset; G Créhange
Journal:  Oncoimmunology       Date:  2017-11-27       Impact factor: 8.110

7.  Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.

Authors:  Inti Zlobec; Alessandro Lugli
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

8.  The pathologist's role in rectal cancer patient assessments.

Authors:  Joseph E Willis
Journal:  Clin Colon Rectal Surg       Date:  2007-08

9.  The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients.

Authors:  N P West; M Dattani; P McShane; G Hutchins; J Grabsch; W Mueller; D Treanor; P Quirke; H Grabsch
Journal:  Br J Cancer       Date:  2010-04-20       Impact factor: 7.640

Review 10.  Proforma-based reporting in rectal cancer.

Authors:  F Taylor; N Mangat; I R Swift; G Brown
Journal:  Cancer Imaging       Date:  2010-10-04       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.